Brief: Dawnrays pharmaceutical says enters into JV agreement with Zhongshan KF
Dec 14 (Reuters) - Dawnrays Pharmaceutical Holdings Ltd
2348.HK :
* Agreement for purpose of establishing jv co and regulating
management arrangements and rights of dawnrays biotech and
zhongshan kf
* Dawnrays biotech, a wholly-owned subsidiary of company,
and zhongshan kf entered into jv agreement
* The total investment amount of jv co is rmb243.5 million
Source text for Eikon: ID:nHKS5L4yWW
Further company coverage: 2348.HK
((Bangalore.newsroom@thomsonreuters.com ;))
Recent news on Dawnrays Pharmaceutical (Holdings)
See all newsBrief: Dawnrays Pharmaceutical Says Suzhou Dawnrays Commits To Invest Up To RMB100 Mln In Partnership
Brief: Dawnrays Pharmaceutical (Holdings) Final Dividend Of Hk$0.048 Per Share
Brief: Dawnrays Pharmaceutical Reports HY Net Income Attributable Of RMB104.6 MLN
Brief: Dawnrays Pharmaceutical (Holdings) Posts FY Profit Attributable Of Rmb564.9 Million
Brief: Dawnrays Pharmaceutical (Holdings) Appoints Yu Liwei To Act As CEO